Rubius Therapeutics, Inc. (RUBY) has 20 known insider and institutional holders on record. The largest holder is Flagship Ventures Fund IV General Partner LLC with 2,633,703 shares. Other notable holders include Epstein David R and NISSEN TORBEN STRAIGHT.
RUBY Insider Ownership
Top Holder
Flagship Ventures Fund IV General Partner LLC
2,633,703 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Flagship Ventures Fund Iv General Partner Llc |
10 Percent Owner |
2,633,703 |
2021-03-23 |
|
| 2 |
Epstein David R |
Director |
499,762 |
2022-05-13 |
|
| 3 |
Nissen Torben Straight |
President |
82,854 |
2019-07-26 |
|
| 4 |
Cagnoni Pablo J |
Director |
66,082 |
2023-02-01 |
|
| 5 |
Schaffert Susanne |
Director |
50,000 |
2022-08-01 |
|
| 6 |
Carpenter Christopher L. |
Chief Medical Officer |
34,843 |
2019-12-18 |
|
| 7 |
Carmona Jose |
Chief Financial Officer |
34,500 |
2022-02-01 |
|
| 8 |
Coughlin Christina M. |
Chief Medical Officer |
32,300 |
2021-02-02 |
|
| 9 |
Cuss Francis M |
Director |
25,000 |
2022-05-13 |
|
| 10 |
Langer Robert |
Director |
25,000 |
2019-05-28 |
|
| 11 |
Symonds Jonathan |
Director |
25,000 |
2022-05-13 |
|
| 12 |
Rosenblatt Michael |
Director |
25,000 |
2022-05-13 |
|
| 13 |
Afeyan Noubar |
10 Percent Owner |
25,000 |
2022-05-13 |
|
| 14 |
Sohn Catherine A. |
Director |
25,000 |
2022-05-13 |
|
| 15 |
Prener Anne |
Director |
25,000 |
2022-05-13 |
|
| 16 |
Holles Natalie C. |
Director |
25,000 |
2022-05-13 |
|
| 17 |
Appelhans Dannielle |
CEO and President |
14,263 |
2023-02-01 |
|
| 18 |
Turka Laurence A. |
Chief Scientific Officer |
12,359 |
2023-01-31 |
|
| 19 |
Keson-brookes Maiken |
CLO & Corp. Secretary |
8,075 |
2022-02-01 |
|
| 20 |
Oh Andrew M. |
Chief Financial Officer |
5,000 |
2020-05-19 |
|
No ownership data available for RUBY.
